Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BCC 2021 | Focus of the Oncoplastic Breast Consortium

Walter Weber • 12 Mar 2021
BCC 2021
Breast Cancer

Walter Weber, MD, University Hospital Basel, Basel, Switzerland, discusses the focus of the Oncoplastic Breast Consortium including developing current standards of oncoplastic surgery, ongoing randomized trials such as the OPBC-02 PREPEC study (NCT04293146), and addressing knowledge gaps in the field of oncoplastic surgery. This interview took place during the 17th St. Gallen International Breast Cancer Conference.

More from Walter Weber

PREPEC (OPBC-02): pre-pectoral vs sub-pectoral IBBR after mastectomy
0:42
PREPEC (OPBC-02): pre-pectoral vs sub-pectoral IBBR after mastectomy
Walter Weber • 30 May 2026
Evaluating the role of axillary surgery after neoadjuvant chemotherapy
2:12
Evaluating the role of axillary surgery after neoadjuvant chemotherapy
Walter Weber • 13 Mar 2025
Current indications for axillary dissection in breast cancer
1:28
Current indications for axillary dissection in breast cancer
Walter Weber • 13 Mar 2025
Selecting patients with breast cancer who can avoid axillary surgery
1:18
Selecting patients with breast cancer who can avoid axillary surgery
Walter Weber • 13 Mar 2025

Related Videos

Stress and depression linked to tumor transcriptional signatures in breast cancer
1:21
Stress and depression linked to tumor transcriptional signatures in breast cancer
Shipra Gandhi • 31 May 2026
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
1:13
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
Shipra Gandhi • 31 May 2026
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
1:34
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
Shipra Gandhi • 1 Jun 2026
HELEN-Trio 011: camrelizumab plus chemotherapy as neoadjuvant therapy in TNBC
0:49
HELEN-Trio 011: camrelizumab plus chemotherapy as neoadjuvant therapy in TNBC
Shipra Gandhi • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals